SARS-CoV-2/Influenza A+B Antigen Combo Rapid Test Kit (Colloidal Gold)

This product uses immunochromatographic technology to rapidly screen for influenza A and B viruses by collecting nasal or throat secretions in a single test, serving as the preferred tool for early screening of influenza.

A rapid test kit for the detection of SARS-CoV-2 antigens using colloidal gold technology. This kit enables rapid point-of-care testing for COVID-19 detection.

Rapid antigen detection kit for SARS-CoV-2 using colloidal gold immunochromatography. Delivers qualitative results for COVID-19 diagnosis in clinical and point-of-care settings. Designed for swift patient screening and laboratory confirmation protocols.

An in vitro qualitative diagnostic test kit for detecting COVID-19 antigen N protein in human nasal, nasopharyngeal, and oropharyngeal samples using colloidal gold solid-phase immunochromatography. The kit uses a double antibody sandwich immunoassay principle with a test cassette, swabs, extraction tube, and buffer solution. Results are interpreted within 15 minutes by observing colored bands at control and test lines on the cassette. The kit is intended as a supplementary or auxiliary diagnostic indicator and requires confirmation of positive results; negative results do not exclude infection possibility.

Rapid HIV-1/2 antibody and p24 antigen combo immunochromatographic test kit using colloidal gold technology for point-of-care detection. Designed for serological screening and early-stage HIV diagnosis in clinical and laboratory settings. Detects both antibodies and p24 antigen in a single test, enabling simultaneous identification of acute and established infections.

Rapid antigen test for simultaneous detection of SARS-CoV-2 and Influenza A+B from respiratory specimens. Delivers results within 15-20 minutes, enabling quick triage and differential diagnosis in clinical and point-of-care settings. Colloidal gold immunochromatographic technology provides high sensitivity and specificity for acute respiratory infection management.

A rapid visual immunoassay for qualitative detection of Influenza A and B antigens using colloidal gold technology. Provides presumptive results for respiratory infection screening.

A rapid antigen test kit for detecting SARS-CoV-2 virus. This colloidal gold platform-based diagnostic kit provides quick results for COVID-19 screening.

Utilizes Colloidal Gold Immunochromatographic Assay and Fluorescence Immunoassay technologies to support rapid antigen detection for Influenza A/B, RSV, COVID-19, ADV, HMPV, PIV, and co-infection panels. Designed for professional point-of-care testing (POCT) environments in hospital emergency departments and public health programs. Compatible with nasopharyngeal and nasal swab samples with CE-IVD compliant formats and shelf life up to 36 months at 2–30°C.

A rapid antigen test kit for COVID-19 detection using colloidal gold immunochromatographic method.

Respiratory disease rapid test kits that detect a wide range of pathogens including influenza A/B, RSV, SARS-CoV-2 and more. Using Colloidal Gold and Fluorescence Immunoassay technologies with multiplex respiratory panel formats available, they support early intervention and point-of-care respiratory testing.

Rapid antigen detection kit for SARS-CoV-2 designed for home-use testing. Provides qualitative detection of COVID-19 virus using colloidal gold chromatography technology.